Claims for Patent: 5,176,912

Summary for Patent: 5,176,912

Title:	Method of treating psoriasis
Abstract:	A method of treating psoriasis which includes subcutaneously injecting into the tissue of a person a dose of cc of a mixture composed of 0.1 milligrams histamine phosphate, 9.25 milligrams bacteriologic peptadase, 110.00 milligrams diprophylline, 4.0 milligrams chlorophenamine, about 0.1 milligram methyl paraben and propylparaben, about 0.2 milligrams sodium chloride, water and then observing the site for between one and three days to observe when the tissue surface at the site is no longer inflamed and is normal and, then, successively injecting 1 cc again and again with a similar observation interval for a period of about two weeks to develop a tolerance to the mixture; and thereafter, repeating the process of injecting every twenty-four hours to seventy-two hours with a 2 cc injection until the symptoms of the psoriasis condition disappear.
Inventor(s):	Cabezas; Orestes (Miami, FL)
Assignee:
Application Number:	07/647,245
Patent Claims:	1. The method of treating psoriasis comprising the steps of: a) first injecting subcutaneously in the tissue of a person at a site on the person one cc of a mixture, said mixture comprising per millimeter: 0.1 milligrams histamine phosphate 9.25 milligrams bacteriologic peptadase 110.00 milligrams diprophylline 4.0 milligrams chlorophenamine about 0.1 milligram methyl paraben and propylparaben about 0.2 milligrams sodium chloride Water; b) second, when the tissue surface at the site is no longer inflamed and is normal, inject 1 cc again; c) third, repeat the second step of this process for a period to develop tolerance to the mixture; d) fourth, after the period of about two weeks to develop tolerance, inject no more that 2 cc's per injection until the symptoms of the psoriasis condition disappear. 2. The method of claim 1 wherein 2 cc's are injected per injection in performing the fourth step. 3. The method of claim 1 wherein the site is on the inside forearm of the person. 4. The method of claim 1 wherein the period of the third step is at least two weeks. 5. The method of claim 3 wherein the period of the third step is at least two weeks.

Details for Patent 5,176,912

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Alk-abello, Inc.	HISTATROL	positive skin test control-histamine	Injection	103754	09/29/1950		2040-01-29
Jubilant Hollisterstier Llc	N/A	positive skin test control-histamine	Injection	103891	03/13/1924		2040-01-29